Explain this page
Arphra AIPlain-English read on Eli Lilly and Company’s valuationConsensus target
$1266.17+11.8%
$1119$1400
Low $1119Median $1270High $1400
Rating distribution
No rating distribution on file.
Recent rating actions
· analyst_gradeslatest 10
| Firm | Action | Grade | Date |
|---|---|---|---|
| May 01, 2026 | |||
| Apr 01, 2026 | |||
| Mar 01, 2026 | |||
| Feb 01, 2026 | |||
| Jan 01, 2026 | |||
| Dec 01, 2025 | |||
| Nov 01, 2025 | |||
| Oct 01, 2025 | |||
| Sep 01, 2025 | |||
| Aug 01, 2025 |
Composite rating
B
Score 3/5
Consensus
—
0 buy / 0 hold / 0 sell
Target consensus
$1,266.17
+11.75% vs spot
Recent activity
1 ratings
Last 30 days
Ratings snapshot
DB · ratings_historyJun 06, 2026Composite
B
3/5 score
Components (1-5)
- Discounted CF4
- Return on equity5
- Return on assets5
- Debt / equity1
- Price / earnings1
- Price / book1
Grades consensus
DB · analyst_gradesMay 01, 2026Consensus
—
0 firms tracked
- Strong Buy0
- Buy0
- Hold0
- Sell0
- Strong Sell0
Price target · summary
DB · price_targets_historyJun 06, 2026Last month
$1,266.17
1 snapshots+11.75%
Last quarter
$1,261.04
3 snapshots+11.30%
Last year
$1,261.04
3 snapshots+11.30%
All-time
$1,261.04
3 snapshots+11.30%
Low
$1,119.00
-1.24% vs spot
Median
$1,270.00
+12.09% vs spot
High
$1,400.00
+23.57% vs spot
Target consensus · 2y
DB$1,258.47 → $1,266.17May 2026 consensus high low spotJun 2026
Estimate revisions · forward years
DBSell-side consensus EPS / Revenue / EBITDA over time, per forward fiscal year.
2026-12-31
1 snapshots
EPS—
Revenue ($B)—
2027-12-31
1 snapshots
EPS—
Revenue ($B)—
2028-12-31
1 snapshots
EPS—
Revenue ($B)—
Peer comparables
Green = best, red = worst (per column)Analyst grade actions — 5 years
Stacked monthly counts5y total0 upgrades36 holds / reiterations0 downgrades
Historical stock grades
DB · analyst_grades36| Date | Firm | Action | Previous | New | |
|---|---|---|---|---|---|
| May 01, 2026 | — | → | |||
| Apr 01, 2026 | — | → | |||
| Mar 01, 2026 | — | → | |||
| Feb 01, 2026 | — | → | |||
| Jan 01, 2026 | — | → | |||
| Dec 01, 2025 | — | → | |||
| Nov 01, 2025 | — | → | |||
| Oct 01, 2025 | — | → | |||
| Sep 01, 2025 | — | → | |||
| Aug 01, 2025 | — | → | |||
| Jul 01, 2025 | — | → | |||
| Jun 01, 2025 | — | → | |||
| May 01, 2025 | — | → | |||
| Apr 01, 2025 | — | → | |||
| Mar 01, 2025 | — | → | |||
| Feb 01, 2025 | — | → | |||
| Jan 01, 2025 | — | → | |||
| Dec 01, 2024 | — | → | |||
| Nov 01, 2024 | — | → | |||
| Oct 01, 2024 | — | → | |||
| Sep 01, 2024 | — | → | |||
| Aug 01, 2024 | — | → | |||
| Jul 01, 2024 | — | → | |||
| Jun 01, 2024 | — | → | |||
| May 01, 2024 | — | → | |||
| Apr 01, 2024 | — | → | |||
| Mar 01, 2024 | — | → | |||
| Feb 01, 2024 | — | → | |||
| Jan 01, 2024 | — | → | |||
| Dec 01, 2023 | — | → |
Historical ratings
DB · ratings_history90| Date | Composite | Score | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| Jun 06, 2026 | B | 3 | 4 | 5 | 5 | 1 | 1 | 1 |
| May 02, 2026 | B | — | — | — | — | — | — | — |
| May 01, 2026 | B | — | — | — | — | — | — | — |
| Apr 30, 2026 | B+ | — | — | — | — | — | — | — |
| Apr 29, 2026 | B | — | — | — | — | — | — | — |
| Apr 28, 2026 | B | — | — | — | — | — | — | — |
| Apr 27, 2026 | B | — | — | — | — | — | — | — |
| Apr 24, 2026 | B | — | — | — | — | — | — | — |
| Apr 23, 2026 | B | — | — | — | — | — | — | — |
| Apr 22, 2026 | B | — | — | — | — | — | — | — |
| Apr 21, 2026 | B | — | — | — | — | — | — | — |
| Apr 20, 2026 | B | — | — | — | — | — | — | — |
| Apr 17, 2026 | B | — | — | — | — | — | — | — |
| Apr 16, 2026 | B | — | — | — | — | — | — | — |
| Apr 15, 2026 | B | — | — | — | — | — | — | — |
| Apr 14, 2026 | B | — | — | — | — | — | — | — |
| Apr 13, 2026 | B | — | — | — | — | — | — | — |
| Apr 10, 2026 | B | — | — | — | — | — | — | — |
| Apr 09, 2026 | B | — | — | — | — | — | — | — |
| Apr 08, 2026 | B | — | — | — | — | — | — | — |
| Apr 07, 2026 | B | — | — | — | — | — | — | — |
| Apr 06, 2026 | B | — | — | — | — | — | — | — |
| Apr 02, 2026 | B | — | — | — | — | — | — | — |
| Apr 01, 2026 | B | — | — | — | — | — | — | — |